A Human Kidney Tubuloid Model of Repeated Cisplatin‐Induced Cellular Senescence and Fibrosis for Drug Screening
In advancing pathophysiological models to assess renal drug responses, kidney organoids derived from human pluripotent stem cells mark notable progress. However, replicating aging- and senescence-related pathologies remains a challenge. In this study, an alternative model is introduced using "tubuloids"-epithelial-like structures generated from primary human renal proximal tubular epithelial cells (hRPTECs) isolated from resected human kidneys. Bulk RNA-seq deconvolution confirmed that tubuloids are highly differentiated and predominantly composed of proximal tubule-like cells. Exposure to cisplatin increased γH2AX, Kidney Injury Molecule-1, and Cleaved Caspase-3, markers for DNA damage response, epithelial damage, and apoptosis, respectively. Repeated cisplatin administration resulted in the upregulation of senescence markers and secretion of inflammatory cytokines, consistent with a senescence-associated secretory phenotype (SASP). Supernatants from cisplatin-treated tubuloids triggered myofibroblast activation, suggesting early fibrotic changes. A hRPTEC-derived tubuloid model of cisplatin-induced kidney injury is successfully developed that mimics senescence, SASP, and fibrosis-hallmarks of chronic kidney disease. This model offers a promising human-relevant platform for studying renal epithelial responses and drug screening.
Authors
- Eisei Sohara (ORCID: https://orcid.org/0000-0003-1668-8308)
- Takayasu Mori (ORCID: https://orcid.org/0000-0002-9308-7787)
- Yuji Nashimoto (ORCID: https://orcid.org/0000-0002-2378-5651)
- Yutaro Mori (ORCID: https://orcid.org/0000-0002-8499-5636)
- Yuta Sekiguchi
- Shintaro Mandai (ORCID: https://orcid.org/0000-0001-6709-306X)
- Makiko Mori (ORCID: https://orcid.org/0000-0003-3427-2461)
- Fumiaki Ando (ORCID: https://orcid.org/0000-0002-8401-1705)
- Kensuke Miyake (ORCID: https://orcid.org/0000-0003-1149-3755)
- Hiroaki Kikuchi (ORCID: https://orcid.org/0000-0001-7722-4131)
- Yuma Waseda (ORCID: https://orcid.org/0000-0002-9319-1373)
- Soichiro Yoshida (ORCID: https://orcid.org/0000-0003-2757-8083)
- Takehiro FUJIKI
- Ayumi Suzuki (ORCID: https://orcid.org/0000-0002-6666-573X)
- Hirokazu Kaji (ORCID: https://orcid.org/0000-0003-2566-4172)
- Yuki Nakao (ORCID: https://orcid.org/0009-0008-2937-9858)
- Koichiro Susa (ORCID: https://orcid.org/0000-0002-0100-4527)
- Shin‐ichi Uchida
- I. Morita
- Yasuhisa Fujii
- Ryota Shindoh
Institutions
- Tokyo Medical and Dental University (JP)
- Systems Biology Institute (JP)
- Japan Research Institute (JP)
Publication Details
- Journal
- Advanced Healthcare Materials
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1002/adhm.202501795
- Citations
- 1
- Primary Topic
- Renal and related cancers
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Japan Agency for Medical Research and Development
- Ministry of Education, Culture, Sports, Science and Technology
- Tokyo Medical and Dental University
- Bayer Yakuhin
- Japan Society for the Promotion of Science